Agilent Technologies, Inc. $A Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC increased its position in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 1.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,319,530 shares of the medical research company’s stock after buying an additional 115,183 shares during the quarter. Geode Capital Management LLC owned about 2.58% of Agilent Technologies worth $860,137,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Stone House Investment Management LLC acquired a new stake in shares of Agilent Technologies during the first quarter worth about $30,000. Ransom Advisory Ltd acquired a new position in Agilent Technologies during the 1st quarter worth approximately $32,000. Central Pacific Bank Trust Division purchased a new stake in shares of Agilent Technologies in the 2nd quarter valued at approximately $33,000. Zions Bancorporation National Association UT acquired a new stake in shares of Agilent Technologies in the 1st quarter valued at $38,000. Finally, Costello Asset Management INC purchased a new stake in shares of Agilent Technologies during the 1st quarter worth $47,000. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Agilent Technologies Stock Down 3.1%

Agilent Technologies stock opened at $146.75 on Friday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The firm has a market capitalization of $41.60 billion, a price-to-earnings ratio of 34.45, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29. The stock’s fifty day moving average is $137.27 and its two-hundred day moving average is $123.50. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25.

Agilent Technologies (NYSE:AGet Free Report) last announced its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s payout ratio is currently 23.24%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Rothschild & Co Redburn started coverage on Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price on the stock. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. JPMorgan Chase & Co. lifted their price target on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Finally, TD Cowen lifted their target price on Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $149.62.

Read Our Latest Analysis on Agilent Technologies

About Agilent Technologies

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Featured Stories

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.